MicroRNA-328 ameliorates oxidized low-density lipoprotein-induced endothelial cells injury through targeting HMGB1 in

Chun-Yang Wu1, Zhao-Feng Zhou1, Bin Wang1

  • 1Department of Cardiology, Yancheng Hospital Affiliated to Southeast University School of Medicine, Yancheng, China.

Insights

MicroRNA-328 protects against atherosclerosis by reducing inflammation and oxidative stress in endothelial cells. It targets high-mobility group box-1 (HMGB1), mitigating damage caused by oxidized low-density lipoprotein (ox-LDL).

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Pathology

Background:

  • Atherosclerosis is a chronic inflammatory disease impacting blood vessels.
  • MicroRNAs (miRNAs) are key regulators in various diseases, including atherosclerosis.
  • The specific role of miR-328 in atherosclerosis has been underexplored.

Purpose of the Study:

  • To investigate the role of miR-328 in endothelial cell injury during atherosclerosis.
  • To determine how oxidized low-density lipoprotein (ox-LDL) affects miR-328 expression and endothelial cell function.
  • To identify downstream targets of miR-328 involved in atherosclerosis.

Main Methods:

  • Oxidized low-density lipoprotein (ox-LDL) was used to induce injury in human umbilical vein endothelial cells (HUVECs).
  • Cell viability, apoptosis, inflammation, and oxidative stress were assessed.
  • miR-328 mimics and inhibitors were used to modulate miR-328 levels.
  • Bioinformatics analysis and experimental validation were employed to identify miR-328 targets.

Main Results:

  • ox-LDL induced HUVEC apoptosis, reduced cell viability, and promoted inflammation and oxidative stress.
  • ox-LDL treatment decreased miR-328 expression in HUVECs.
  • Overexpression of miR-328 repressed ox-LDL-induced apoptosis and inflammation, while enhancing cell survival.
  • Inhibition of miR-328 exacerbated ox-LDL-induced endothelial cell injury.
  • High-mobility group box-1 (HMGB1) was identified as a direct downstream target of miR-328.

Conclusions:

  • miR-328 plays a protective role against ox-LDL-induced endothelial cell injury in atherosclerosis.
  • miR-328 ameliorates endothelial cell damage by targeting HMGB1.
  • These findings highlight miR-328 as a potential therapeutic target for atherosclerosis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Oxidation Numbers03:14

Oxidation Numbers

In redox reactions, the transfer of electrons occurs between reacting species. Electron transfer is described by a hypothetical number called the oxidation number (or oxidation state). It represents the effective charge of an atom or element, which is assigned using a set of rules.
42.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
412
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
168.8K